Study compares the risk of nonarteritic anterior ischemic optic neuropathy (NAION) in new users of semaglutide versus sodium-glucose cotransporter 2 (SGLT2) inhibitors.
Protein just got a big boost from U.S. health officials. in their latest dietary guidelines. But nutritionists say Americans are already consuming more than they need.
The term ‘food noise’ has emerged alongside the popularity of glucagon-like peptide-1 receptor agonists—known as GLP-1 medications—that treat Type 2 diabetes and obesity.
Study compares cardiovascular outcomes of weekly tirzepatide versus dulaglutide in patients with type 2 diabetes and atherosclerotic cardiovascular disease.
